Target intelligence / Profile preview

Transcription elongation factor 1 homolog (ELOF1)

Target
ELOF1
Molecular classification
Transcription factor, Transcription elongation factor, DNA repair protein, Zinc-finger protein
01

Overview

Transcription elongation factor 1 homolog (ELOF1) is a small, evolutionarily conserved zinc-finger protein that functions primarily as an integral part of the RNA Polymerase II (Pol II) transcription elongation complex[1][3]. ELOF1 modulates transcription elongation by interacting directly with Pol II subunits and other elongation factors such as TFIIS, SPT5, SPT6, and the PAF complex[1][2][3]. Beyond its role in transcription, ELOF1 is essential for transcription-coupled nucleotide excision repair (TC-NER), promoting recruitment of repair factors (UVSSA, TFIIH) and coordinating the ubiquitylation of stalled Pol II to initiate DNA repair at transcription-blocking lesions[1][3][4]. ELOF1 deficiency leads to UV hypersensitivity, impaired transcriptional elongation rates, and increased replication stress, manifesting as genomic instability and potential synthetic lethality when combined with loss of other elongation factors[1][3]. No direct drugs or clinical biomarkers are currently associated with ELOF1, but its critical role in genome maintenance makes it a relevant molecular target for research in cancer biology and DNA repair pathways.

Other names
ELOF1ELF1MGC4549Transcription elongation factor 1 homologELF1 homologelongation factor 1 homolog (ELF1, S. cerevisiae)elongation factor 1
02

Biological functions

Transcription elongationDNA damage responseGenome stabilityProtein–protein interaction within transcription machinery
03

Disease associations

CancerOther
04

Safety considerations

Genomic instabilityEmbryonic lethality

Beyond the preview

Go deeper on Transcription elongation factor 1 homolog (ELOF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription elongation factor 1 homolog (ELOF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call